The global autoimmune disease diagnosis market size reached US$ 3.9 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 6.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.66% during 2023-2032. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent some of the key factors driving the market.
An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems.
It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.
Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.
Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
3. What is the expected growth rate of the global autoimmune disease diagnosis market?
4. What are the key factors driving the global autoimmune disease diagnosis market?
5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
8. What are the key regions in the global autoimmune disease diagnosis market?
9. Who are the key players/companies in the global autoimmune disease diagnosis market?
An autoimmune disease is a group of disorders wherein the immune system attacks the cells, tissues, and organs of the body. It can be caused by different medical conditions, such as systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. It is associated with fatigue, joint pain and stiffness, skin rashes, fever, and digestive problems.
It can also cause damage to organs and tissues, which leads to more severe symptoms like difficulty breathing, organ failure, or even death. It can be diagnosed via a combination of various approaches, such as taking a detailed medical history, performing a physical examination, blood tests to detect specific antibodies, imaging tests to look for damage or inflammation, and a biopsy to examine the affected tissue under a microscope.
Autoimmune Disease Diagnosis Market Trends:
The surging incidences of autoimmune diseases among individuals and the increasing aging population that are susceptible to develop such medical conditions represent one of the major factors driving the demand for autoimmune disease diagnosis around the world. Moreover, the rising awareness about autoimmune disease, its symptoms, diagnosis, and the easy availability of the treatment options is favoring the growth of the market. In addition, the growing implementation of health insurance policies that offer financial assistance for autoimmune disease diagnosis or treatment and reduce overall medical expenses is influencing the market positively.Apart from this, governing authorities of several countries are financing research and development (R&D) projects to study autoimmune diseases and develop new treatments. They are also investing in programs that aim to develop improved diagnostic methods for these medical disorders. Besides this, they are undertaking initiatives to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
Furthermore, there is an increase in the use of electronic medical records (EMRs) to improve the accuracy and speed of autoimmune disease diagnosis as healthcare professionals have access to more comprehensive patient information. This, along with the rising adoption of telemedicine is catalyzing the demand for remote autoimmune disease diagnosis and monitoring technologies. Besides this, the growing demand for non invasive diagnosis, which is less painful as compared to traditional diagnostic procedures, is creating a positive outlook for the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global autoimmune disease diagnosis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, disease type, test type, and end-user.Product Type Insights:
- Consumables and Assay Kits
- Instruments
Disease Type Insights:
- Systemic Autoimmune Disease
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis
- Others
- Localized Autoimmune Disease
- Inflammatory Bowel Disease
- Type 1 Diabetes
- Thyroid
- Others
Test Type Insights:
- Routine Laboratory Tests
- Inflammatory Markers
- Autoantibodies and Immunologic Tests
- Others
End-User Insights:
- Clinical Laboratories
- Hospitals
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global autoimmune disease diagnosis market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.Some of the companies covered include Abbott Laboratories, AESKU.GROUP, Danaher Corp., bioMérieux SA, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hemagen Diagnostics, Inc., Inova Diagnostics, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech plc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What is the size of the global autoimmune disease diagnosis market?2. What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?
3. What is the expected growth rate of the global autoimmune disease diagnosis market?
4. What are the key factors driving the global autoimmune disease diagnosis market?
5. What is the breakup of the global autoimmune disease diagnosis market based on the product type?
6. What is the breakup of the global autoimmune disease diagnosis market based on the disease type?
7. What is the breakup of the global autoimmune disease diagnosis market based on the test type?
8. What are the key regions in the global autoimmune disease diagnosis market?
9. Who are the key players/companies in the global autoimmune disease diagnosis market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Autoimmune Disease Diagnosis Market
6 Market Breakup by Product Type
7 Market Breakup by Disease Type
8 Market Breakup by Test Type
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- AESKU.GROUP
- Danaher Corp.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- Hemagen Diagnostics Inc.
- Inova Diagnostics Inc.
- Myriad Genetics Inc.
- Quest Diagnostics Incorporated
- Siemens Healthineers AG
- SQI Diagnostics
- Thermo Fisher Scientific Inc.
- Trinity Biotech plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 142 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 3.9 Billion |
| Forecasted Market Value ( USD | $ 6.4 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
